New-Onset Atrial Fibrillation is Associated With Cardiovascular Events Leading to Death in a First Time Myocardial Infarction Population of 89 703 Patients With Long-Term Follow-Up: A Nationwide Study

被引:64
作者
Bang, Casper N. [1 ,2 ]
Gislason, Gunnar H. [3 ,4 ]
Greve, Anders M. [1 ]
Bang, Christian A. [3 ]
Lilja, Alexander [3 ]
Torp-Pedersen, Christian [3 ]
Andersen, Per K. [5 ]
Kober, Lars [1 ]
Devereux, Richard B. [2 ]
Wachtell, Kristian [3 ]
机构
[1] Rigshosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark
[2] Weill Cornell Med Coll, Dept Med, New York, NY USA
[3] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark
[4] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark
[5] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2014年 / 3卷 / 01期
关键词
cardiovascular mortality; mortality; myocardial infarction; new-onset atrial fibrillation; re-myocardial infarction; stroke; PROGNOSTIC-SIGNIFICANCE; CORONARY INTERVENTION; RISK STRATIFICATION; MORTALITY; DENMARK; STROKE; THROMBOEMBOLISM; PRESCRIPTION; PREDICTION; INITIATION;
D O I
10.1161/JAHA.113.000382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-New-onset atrial fibrillation (AF) is reported to increase the risk of death in myocardial infarction (MI) patients. However, previous studies have reported conflicting results and no data exist to explain the underlying cause of higher death rates in these patients. Methods and Results-All patients with first acute MI between 1997 and 2009 in Denmark, without prior AF, were identified from Danish nationwide administrative registers. The impact of new-onset AF on all-cause mortality, cardiovascular death, fatal/nonfatal stroke, fatal/nonfatal re-infarction and noncardiovascular death, were analyzed by multiple time-dependent Cox models and additionally in propensity score matched analysis. In 89 703 patients with an average follow-up of 5.0 +/- 3.5 years event rates were higher in patients developing AF (n=10 708) versus those staying in sinus-rhythm (n=78 992): all-cause mortality 173.9 versus 69.4 per 1000 person-years, cardiovascular death 137.2 versus 50.0 per 1000 person-years, fatal/nonfatal stroke 19.6/19.9 versus 6.2/5.6 per 1000 person-years, fatal/nonfatal re-infarction 29.0/60.7 versus 14.2/37.9 per 1000 person-years. In time-dependent multiple Cox analyses, new-onset AF remained predictive of increased all-cause mortality (HR: 1.9 [95% CI: 1.8 to 2.0]), cardiovascular death (HR: 2.1 [2.0 to 2.2]), fatal/nonfatal stroke (HR: 2.3 [2.1 to 2.6]/HR: 2.5 [2.2 to 2.7]), fatal/nonfatal re-infarction (HR: 1.7 [1.6 to 1.8]/HR: 1.8 [1.7 to 1.9]), and non-cardiovascular death (HR: 1.4 [1.3 to 1.5]) all P<0.001). Propensity-score matched analyses yielded nearly identical results (all P<0.001). Conclusions-New-onset AF after first-time MI is associated with increased mortality, which is largely explained by more cardiovascular deaths. Focus on the prognostic impact of post-infarct AF is warranted.
引用
收藏
页数:9
相关论文
共 37 条
[1]   Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors [J].
Adam, Oliver ;
Neuberger, Hans-Ruprecht ;
Boehm, Michael ;
Laufs, Ulrich .
CIRCULATION, 2008, 118 (12) :1285-1293
[2]   COX REGRESSION-MODEL FOR COUNTING-PROCESSES - A LARGE SAMPLE STUDY [J].
ANDERSEN, PK ;
GILL, RD .
ANNALS OF STATISTICS, 1982, 10 (04) :1100-1120
[3]   Restrictive Left Ventricular Filling Pattern and Risk of New-Onset Atrial Fibrillation After Acute Myocardial Infarction [J].
Aronson, Doron ;
Mutlak, Diab ;
Bahouth, Fadel ;
Bishara, Rema ;
Hammerman, Haim ;
Lessick, Jonathan ;
Carasso, Shemy ;
Dabbah, Saleem ;
Reisner, Shimon ;
Agmon, Yoram .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (12) :1738-1743
[4]   Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction [J].
Bahouth, Fadel ;
Mutlak, Diab ;
Furman, Moran ;
Musallam, Anees ;
Hammerman, Haim ;
Lessick, Jonathan ;
Dabbah, Saleem ;
Reisner, Shimon ;
Agmon, Yoram ;
Aronson, Doron .
HEART, 2010, 96 (09) :683-688
[5]   Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study [J].
Bang, Casper N. ;
Greve, Anders M. ;
Boman, Kurt ;
Egstrup, Kenneth ;
Gohlke-Baerwolf, Christa ;
Kober, Lars ;
Nienaber, Christoph A. ;
Ray, Simon ;
Rossebo, Anne B. ;
Wachtell, Kristian .
AMERICAN HEART JOURNAL, 2012, 163 (04) :690-696
[6]   Relation of inflammation and benefit of statins after percutaneous coronary interventions [J].
Chan, AW ;
Bhatt, DL ;
Chew, DP ;
Reginelli, J ;
Schneider, JP ;
Topol, EJ ;
Ellis, SG .
CIRCULATION, 2003, 107 (13) :1750-1756
[7]   Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience [J].
Crenshaw, BS ;
Ward, SR ;
Granger, CB ;
Stebbins, AL ;
Topol, EJ ;
Califf, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) :406-413
[8]   ATRIAL-FIBRILLATION DEVELOPING IN ACUTE PHASE OF MYOCARDIAL-INFARCTION - PROGNOSTIC IMPLICATIONS [J].
CRISTAL, N ;
PETERBURG, I ;
SZWARCBERG, J .
CHEST, 1976, 70 (01) :8-11
[9]   Landmark Analysis at the 25-Year Landmark Point [J].
Dafni, Urania .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (03) :363-U216
[10]   Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980-1993 [J].
Frost, L ;
Engholm, G ;
Moller, H ;
Husted, S .
EUROPEAN HEART JOURNAL, 1999, 20 (21) :1592-1599